<DOC>
	<DOCNO>NCT01004445</DOCNO>
	<brief_summary>This study part research program see amikacin deliver aerosol directly lungs combination IV antibiotic therapy help intubate patient gram-negative pneumonia get good faster give intravenous antibiotic alone . The primary purpose study determine correct dose amikacin deliver directly lung aerosol via investigational device call Pulmonary Delivery Device System ( PDDS ) .</brief_summary>
	<brief_title>A Study Determine Correct Dose Amikacin Which Delivered Directly Lungs Ventilated Patients Aerosol Via Investigational Device Called Pulmonary Delivery Device System ( PDDS )</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Amikacin</mesh_term>
	<criteria>Male female patient 18 year age old clinical diagnosis VAP , HAP HCAP expect mechanical ventilation least 3 day Patients compromise suppressed immune system , severe hypoxemia , PEEP &gt; 15cm H2O , creatinine &gt; 2 mg/dL , pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Pneumonia</keyword>
	<keyword>Adjunctive treatment</keyword>
	<keyword>Gram-negative bacteria</keyword>
</DOC>